Inogen | INGN - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Abbott USD 3.6B 330M 2026-06
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 82.56M 1.99M 2026-06
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Cooper Companies USD 676.2M 303.1M 2026-03
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Inogen USD 43.77M 510K 2024-06
Insulet USD 344.8M 27.6M 2026-06
Medtronic 2.96B 9M 2025-12
Orthofix International USD 130.35M 11.31M 2025-12
Philips EUR 1.21B 23M 2026-06
ResMed USD 290.65M 10.86M 2026-06
Steris USD 369.7M 17.9M 2026-06
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
X T L Biopharmaceuticals USD 706K 50K 2024-12
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06